Yu Lifang, Marchisio Mario Andrea
School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China.
Front Bioeng Biotechnol. 2020 Sep 30;8:575393. doi: 10.3389/fbioe.2020.575393. eCollection 2020.
Clustered regularly interspaced short palindromic repeats (CRISPR)-Cas (CRISPR-associated proteins), a prokaryotic RNA-mediated adaptive immune system, has been repurposed for gene editing and synthetic gene circuit construction both in bacterial and eukaryotic cells. In the last years, the emergence of the anti-CRISPR proteins (Acrs), which are natural OFF-switches for CRISPR-Cas, has provided a new means to control CRISPR-Cas activity and promoted a further development of CRISPR-Cas-based biotechnological toolkits. In this review, we focus on type I and type V-A anti-CRISPR proteins. We first narrate Acrs discovery and analyze their inhibitory mechanisms from a structural perspective. Then, we describe their applications in gene editing and transcription regulation. Finally, we discuss the potential future usage-and corresponding possible challenges-of these two kinds of anti-CRISPR proteins in eukaryotic synthetic gene circuits.
成簇规律间隔短回文重复序列(CRISPR)-Cas(CRISPR相关蛋白)是一种原核生物的RNA介导的适应性免疫系统,已被重新用于细菌和真核细胞中的基因编辑和合成基因回路构建。在过去几年中,作为CRISPR-Cas天然关闭开关的抗CRISPR蛋白(Acrs)的出现,为控制CRISPR-Cas活性提供了一种新方法,并推动了基于CRISPR-Cas的生物技术工具包的进一步发展。在本综述中,我们重点关注I型和V-A型抗CRISPR蛋白。我们首先讲述抗CRISPR蛋白的发现,并从结构角度分析它们的抑制机制。然后,我们描述它们在基因编辑和转录调控中的应用。最后,我们讨论这两种抗CRISPR蛋白在真核合成基因回路中的潜在未来用途以及相应可能面临的挑战。